In breast tumors, combined with genistein, daidzein decreases the methylation of both BRCA1 and BRCA2 promoters, thus enhancing the BRCA1 and BRCA2 protein levels, and inhibits the MeCP2 expression associated with the entire genome methylation status [118]. This evidence concerns the gene BRCA2 and breast neoplasm.